MOSt
Advisor
Monthly Markets Newsletter
November 2017
In This Issue
Market Outlook for the month
Investment Ideas
• Equity Market Outlook
• Derivatives & Commodities Market Outlook
• Model Advisory Portfolios
• Recommended Funds
• New PMS offerings: Invesco India DAWN Portfolio
Key Highlights
Nifty hits fresh life time highs
Most of the sectorial indices rallied
Bulls got charged up on Recapitalization plan
Dear Investor,
Market in October 2017:
Nifty index witnessed a historic month
as it scaled up previous peak of 10178 and promptly rallied to
hit a new life time high at 10385. Index closed the month with
the decent gains of 5.58% in line with the positive Global
sentiment.
Government took a radical step in announcing the recapitalization plan for PSU Banks
which generated lot of positive sentiment for the segment and overall market. The
RBI policy during the first week of the month also resulted in cutting SLR.
Geo-political tensions were subdued and market has seen all round Bullishness for
individual sectors as the rally was fairly broad based.
So far, 2Q'18 results have been in line with expectation in which private sector Banks
and NBFC have delivered better than expectation while negative surprise is seen from
selective Pharma and Oil Marketing Companies.
Pre. Mth
Global Market
Index
31-Oct 17
MoM (%)
YoY(%)
Sensex
Nifty
FTSE
Dow
Nasdaq
Hang Sang
33,213
10,335
7,493
23,377
6,728
28,246
6.2
5.6
1.6
4.3
3.6
2.5
18.9
19.8
7.8
28.9
29.7
23.2
Economic Pulse
Key Indicators Current Mth
FIIs sold worth INR 7826 Cr. in equity markets for the October month whereas DIIs
bought worth INR 10091 Cr. DIIs are continuously buying from last seven months
and poured more than INR 73000 Cr. in CY17.
INR has appreciated from its high of 65.66 to 64.75 and it is supporting to overall
bullish market sentiment.
Outlook November 2017:
Nifty has been making higher highs - higher lows from
last ten consecutive months and if this formation is negated then only medium term
trend could take a halt else momentum is likely to extend for fresh highs.
Nifty has given the consolidation breakout from its broader trading range of 9685
to 10178. So now till it holds above 10178 zones, rally can extend towards 10550-
10600 and even higher levels, while on the downside immediate support is seen at
10250 levels.
Chandan Taparia
IIP
CPI
10 Year Yield
USD/ INR
Crude ($)
Gold (10 gms)
4.3%
3.28%
6.86%
64.74
61.37
29333
1.2%
3.36%
6.66%
65.28
57.54
29692
Thought for the month
1
 Motilal Oswal Financial Services
On This Page
MOSt
Advisor
Monthly Markets Newsletter
Large Cap Investment Ideas,
Mid Cap Investment Ideas
Must Act
November 2017
Investment Ideas
Dabur India
CMP*:
Target:
INR 333
INR 395
Dabur India is the second largest FMCG company in India, in terms of Product portfolio.
Rural outlook seems to be buoyant and Dabur is likely to report faster growth in rural
sales compared to urban sales. The much-vaunted earnings revival in the sector appears
poised to come through, and rural dependent plays are likely to be at the vanguard.
With expected EPS CAGR of ~18% compared to less than 12% CAGR over FY14-17,
current valuation is attractive. Hence we recommend BUY with PT of INR395.
BUY
Capital First
CMP*:
Target:
INR 755
INR 925
CAFL is a non-deposit-taking NBFC focusing largely on retail lending. It offers loans to
small and medium business enterprises, 2W/CD loans, and also home loans via its sub-
sidiary Capital First Home Finance. While the company has grown its AUM at 26% CAGR
over FY12-17, it has not compromised on asset quality.
BUY
We expect significant margin improvement and stable asset quality to drive RoA/RoE
improvement from 1.6%/12% in FY17 to 1.9%/17% in FY20. We recommend BUY with
PT of 925
PI Industries
CMP*:
Target:
INR 821
INR 890
With the industry witnessing signs of a global agchem revival, we believe PI is well
braced to leverage its strong order book and aid growth, with continuous commercial-
ization of new products (3-4 products expected per year). FY18 is expected to be a back-
ended growth year, with improvement largely expected in the quarters to follow.
We remains positive on the company and value the stock at 25x FY19E EPS. Recom-
BUY
mend BUY with PT of INR890
PNBHF continues to deliver strong growth in its loan book. Increasing geographical spread
and new branch openings (110 branches in FY20E v/s 66 in FY17) are expected to result in
the loan book growing to ~INR1t by FY20 (37% CAGR). With the pace of investments
slowing down, coupled with operating leverage benefits kicking in, the expense ratio is set
to decline meaningfully.
We expect PAT CAGR of 41% over FY17-20E. Recommend Buy with a PT of INR1,750
PNB Housing Finance
CMP*:
Target:
INR 1,423
INR 1,750
BUY
Data as on 31st October 2017.
2
 Motilal Oswal Financial Services
On This Page
MOSt
Advisor
Monthly Markets Newsletter
Equity Market Outlook
Markets & Our Recommendations
November 2017
Equity Market Outlook
Technical Outlook
Nifty witnessed a historic month as the index scaled its previous peak and promptly
USDINR
rallied to make a new life time high at 10385. The price movements of Nifty in last
four months do have a significant implication as it's bullish rising three methods.
This is a continuation pattern and it meant that the consolidation phase is a pause
in the massive up move that we are in since January of this year. The uncertainty
prevalent in last three months is now getting resolved as the buyers seem to be
appearing in full force. The pattern also indicates that the bulls who are of a long
term nature are now readying for more upsides in the Indian market. Nifty also
traded above the 50 DEMA and the average has also started to trend upwards
signifying that the underlying trend in the market is strong.
Nifty Weekly
On the news front, Government took a radical step in announcing the recapital-
ization plan for banks. This generated a very optimistic change in sentiment for
the PSU Banks and overall markets. The RBI policy during the first week of the
month also resulted in RBI cutting the SLR. Geo-Political tensions were subdued
during the month. It was all round bullishness for individual sectors as the rally
was fairly broad based. The top performer was the Nifty Auto and Energy index,
Bank Nifty also performed well while Pharma sector was a gainer but not a spec-
tacular performer. Concluding the market rally this month was broad based with
most sectors performing in line with the overall market sentiment. The breadth is
good and this is a good sign to extend this momentum going forward.
Nifty managed to give consolidation breakout above 10178 and base is continu-
ously shifting higher. Option activity for November series suggests 10200 as an
immediate support with fresh Put writing at 10200 followed by 10000 strikes
while 10500 zones could emerge as a hurdle depicted by highest Call OI concen-
tration. PCR OI moved up from 1.20 to multi year high of 1.68 during the series
and at the same time index also rallied well. Overall rising Put Call Ratio with
falling volatility suggests bullish bias of the market.
Strategy-
Strategy
Nifty is in a sharp uptrend and now it needs to hold above 10300 for
a rally towards 10500-10550. A hold above 25198 is required in Bank Nifty for a
rally of 500-750 points to support the overall indices to head to higher levels.
Nifty Daily
Sectoral Highlights
Sector
Textiles
Pharma
NBFC
Our Views
Positive
Positive
Positive
Top Pick
SRF
Cadila HC
Bajaj Finance
MBP / MSP
Buy / 1689
Buy / 503
Buy / 1800
TGT / SL
1810 / 1630
550 / 480
1980 / 1750
Note: #Technical view for 1 month perspective
3
 Motilal Oswal Financial Services
On This Page
MOSt
Advisor
Monthly Markets Newsletter
Derivatives Market Outlook,
Commodities Market Outlook
Markets & Our Recommendations
November 2017
Derivatives Market Outlook
SECTOR OI
NIFTY - Bull Call Spread
Nifty witnessed rollover of 72.69% V/s 3 MA of 65.41%. Index closed positive
with the gains of 5.88% on expiry to expiry basis. Bank Nifty witnessed rollover
of 68.63% V/s 3 MA of 69.67%. November series started with Open Interest of
Buy 1 Lot 10350 CE,
Sell 1 Lot 10500 CE
Stop Loss
Target
: 40 Points
: 135 Points
23.13mn shares compared to 20.53mn shares seen at the start of October series.
Nifty made a new high of 10355 in the October series and registered the highest
expiry to expiry gains in last 19 series. Overall long built up were seen in Pharma,
Auto, Banks, FMCG and Media stocks.
Auto: Long in Tvsmotor, Maruti and Bajaj Auto while shorts in Amar Raja Battery
Cement: Long in Ultracem, Short covering in Dalmia Bharat, ACC and Grasim
Banks : Long in Federal Bank, PNB while covering in SBIN, Can Bank and ICICI Bank
Metal: Long in Hindalco, National Alum, Short covering in SAIL and Jindalstel
OIL&Gas: Long addition in Gail, Castrol, Short covering in Hindpetro, BPCL and IOC
IT: Long addition in KPIT, Hexaware, Tata Elexsi while short covering in NIIT Tech
Nifty has recently given a range breakout above 10250 zones
Positive momentum with buying in most of the sectors
OI band is shifting higher with maximum Call OI at 10500 strike
Thus, low risk Bull Call Spread is recommended
Commodities Market Outlook
Cruide Oil
Oil prices registered a second consecutive monthly gain in October with Brent trading near two-year highs as fundamentals continue to
improve. Demand growth continues to outpace supply growth and the OPEC's resolve to limit supplies is finally bearing fruit
OPEC oil output fell by 80,000 bpd to 32.78 mbpd in October and overall compliance touched 92%.Russia has also reduced its oil output by
around 317,000 bpd from 11.24 million bpd in Oct 2016. We believe OPEC's compliance would remain high going forward and help continue
the rebalancing process.
US output on the other hand is back near its pre-hurricane levels and remains elevated in y/y comparisons. The growth in production however
seems to have plateaued if the rig count is an indication. US oil rig count fell for a third month in a row in October.
On the inventory side, US oil inventories fell by 10 million barrels last month and are now 6.2% lower compared to the same period last year.
US oil stocks have declined by 80 million barrels since March this year. Global oil stocks likely decreased in Q3 for only the second time since
oil prices crashed in the middle of 2014
Considering that inventories are edging lower, demand remains strong and supply flat, we expect the medium term outlook for oil to remain
positive. A test of $60 for the WTI is likely over the coming months.
4
 Motilal Oswal Financial Services
On This Page
MOSt
Advisor
Monthly Markets Newsletter
MOSt Multi Cap
For Whom :
Investment Duration :
Risk Profile :
Scrip
Hero Motocorp
Zee Entert.
HDFC Bank
Piramal Enterprises
Yes Bank Ltd
CG Consumer Elec.
Can Fin Homes Ltd
Sterling Tools Ltd
P I Industries Ltd
Shriram City Union
Capital First
DHFL
Granules India
Cash
Total
MOSt Multi Cap , MOSt Velocity
Build a Portfolio
November 2017
Long Term Investors
Few months to a year
Moderate Investors
Wtg. Sectoral Allocation
10
10
10
10
10
5
5
5
5
5
5
5
5
5
5
100
In
: NA
We are recommending a MULTI-CAP approach instead of a
MIDCAP approach. The Multi-cap INVESTMENT will have the
following characteristics:
Corpus requirement at INR 10 Lakhs
50% in Large-cap and 50% in mid-cap
15 companies to invest at maximum, 10 minimum
Large-cap stocks are suitable for SIP investments as well
Adheres to our QGLP philosophy
CMP
3850
542
1809
2748
314
221
480
270
821
2306
755
643
140
Out : SRF
Ramco Cements Ltd 718
MOSt Velocity
For Whom :
Investment Duration :
Risk Profile :
Scrip
Tata Motors Ltd
Eicher Motors Ltd
RBL Bank Ltd
Federal Bank Ltd
Dalmia Bharat Ltd
IOC
Cash
Total
Investment Norms: INR 10 lakhs (Model Corpus)
Medium Term Investors
Few months horizon
Moderate Investors
Wtg. Sectoral Allocation
10
5
10
10
10
10
10
35
100
In
: IOC
Jindal Steel & Power
Maximum stocks open : 10
Target Investment Horizon: 1 Year
Cash holding based on market direction call. Cash to be deployed
in case of sharp market falls
Occasional Hedging by buying options
Investment Rationale on every idea is provided
10% in a particular Stock and 30% (max) in a Sector
CMP
428
32233
525
122
2992
416
LIC Housing Finance 599
Out : Ultratech Cement,
5
 Motilal Oswal Financial Services
On This Page
MOSt
Advisor
Monthly Markets Newsletter
MOSt PMS - Model Portfolio
Managed Funds
November 2017
MOSt PMS
Performance since inception
LargeCap PMS:-
VALUE STRATEGY- An amount of 1 cr. Invested in March 2003 is worth INR 25.91 crore (compounded return of 24.94%)
Multi Cap PMS:-
ASK IEP STRATEGY- Amount of 1 cr. Invested in December 2007 is worth INR 4.48 crore (compounded return of 21.3%)
Multi Cap PMS:-
NTDOP STRATEGY- Amount of 1 cr. Invested in December 2007 is worth INR 5.76 crore (compounded return of 19.32%)
Small & Midcap
PMS- - IOP STRATEGY- Amount of 1 cr. Invested in February 2010 is worth INR 3.63 crore (compounded return of 18.17%)
Latest Performance of all OUR THREE PMS (Portfolio Management Services) strategies. (As on 31st Oct. 2017)
6
 Motilal Oswal Financial Services
On This Page
MOSt
Advisor
Monthly Markets Newsletter
Investment Product
Invesco India DAWN Portfolio
November 2017
New PMS offerings: Invesco India DAWN Portfolio
Invesco Asset Management (India) has an average asset base of over INR 32,783.9 Cr.* across Mutual Funds, PMS and offshore advisory
mandates. It offers expertise across equity, fixed income & gold investments with the aim of serving the investment needs of domestic and global
investors (individuals, corporates & institutions). This includes a broad range of best-in-class investment products across asset classes, regions &
risk spectrum, coupled with high standards of customer service. (*For quarter ending September 2017.)
Invesco Limited is one of the world's largest leading independent global investment management firms
US$858.3 billion in assets under management around the globe.
Specialized investment teams managing investments across a wide range of asset classes and investment styles.
Nearly 7,000 employees worldwide.
On-the-ground presence in more than 20 countries, serving clients in more than 120 countries.
Publicly traded on NYSE, S&P 500 constituent; market cap of more than US$ 14 billion
*Source: Invesco data as on June 30 2017
Investment Objective:
To generate capital appreciation by investing in companies available at reasonable valuations
Investment Strategy:-
Exposure to sectors and stocks whose earnings are expected to improve due cyclical recovery
Emphasis on mean reversion & value style investing, with focus on companies with quality business models & management
Allocation to companies which exhibit operating & financial leverage, exposure to under owned companies
Bottom up stock picking approach without bias towards market cap or sector
Portfolio Construct:-
Maximum exposure per stock restricted to 10% at time of initial investments
Concentrated strategy of 15 -25 companies
Current Investment Opportunity
Cyclical recovery sectors: Financials, Industrials, Consumer Discretionary
Under owned sectors for Value style investing: Pharmaceutical, Information Technology
7
 Motilal Oswal Financial Services
Disclosures
The following Disclosures are being made in compliance with the SEBI Research Analyst Regulations 2014 (herein after referred to as the Regulations).
Motilal Oswal Securities Ltd. (MOSL) is a SEBI Registered Research Analyst having registration no. INH000000412. MOSL, the Research Entity (RE) as defined in the Regulations, is engaged in the business of providing Stock broking
services, Investment Advisory Services, Depository participant services & distribution of various financial products. MOSL is a subsidiary company of Motilal Oswal Financial Service Ltd. (MOFSL). MOFSL is a listed public company,
the details in respect of which are available on www.motilaloswal.com. MOSL is registered with the Securities & Exchange Board of India (SEBI) and is a registered Trading Member with National Stock Exchange of India Ltd. (NSE)
and Bombay Stock Exchange Limited (BSE), Metropolitan Stock Exchange Of India Ltd. (MSE) for its stock broking activities & is Depository participant with Central Depository Services Limited (CDSL) & National Securities Depository
Limited (NSDL) and is member of Association of Mutual Funds of India (AMFI) for distribution of financial products. Details of associate entities of Motilal Oswal Securities Limited are available on the website at http://
onlinereports.motilaloswal.com/Dormant/documents/Associate%20Details.pdf
Pending Regulatory Enquiries against Motilal Oswal Securities Limited by SEBI:
SEBI pursuant to a complaint from client Shri C.R. Mohanraj alleging unauthorized trading, issued a letter dated 29th April 2014 to MOSL notifying appointment of an Adjudicating Officer as per SEBI regulations to hold inquiry
and adjudge violation of SEBI Regulations; MOSL requested SEBI to provide all documents, records, investigation report relied upon by SEBI which were referred in Show Cause Notice and also sought personal hearing. The matter
is currently pending.
MOSL, it's associates, Research Analyst or their relative may have any financial interest in the subject company. MOSL and/or its associates and/or Research Analyst may have beneficial ownership of 1% or more securities in the subject
company at the end of the month immediately preceding the date of publication of the Research Report. MOSL and its associate company(ies), their directors and Research Analyst and their relatives may; (a) from time to time,
have a long or short position in, act as principal in, and buy or sell the securities or derivatives thereof of companies mentioned herein. (b) be engaged in any other transaction involving such securities and earn brokerage or other
compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect
to any recommendation and other related information and opinions.; however the same shall have no bearing whatsoever on the specific recommendations made by the analyst(s), as the recommendations made by the analyst(s)
are completely independent of the views of the associates of MOSL even though there might exist an inherent conflict of interest in some of the stocks mentioned in the research report. Research Analyst may have served as director/
officer, etc. in the subject company in the last 12 month period. MOSL and/or its associates may have received any compensation from the subject company in the past 12 months.
In the last 12 months period ending on the last day of the month immediately preceding the date of publication of this research report, MOSL or any of its associates may have:
a) managed or co-managed public offering of securities from subject company of this research report,
b) received compensation for investment banking or merchant banking or brokerage services from subject company of this research report,
c) received compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company of this research report.
d) Subject Company may have been a client of MOSL or its associates during twelve months preceding the date of distribution of the research report.
MOSL and it's associates have not received any compensation or other benefits from the subject company or third party in connection with the research report. To enhance transparency, MOSL has incorporated a Disclosure of
Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report. MOSL and / or its affiliates do and seek to do business including investment banking with companies
covered in its research reports. As a result, the recipients of this report should be aware that MOSL may have a potential conflict of interest that may affect the objectivity of this report. Compensation of Research Analysts is not
based on any specific merchant banking, investment banking or brokerage service transactions. may have a potential conflict of interest that may affect the objectivity of this report. Compensation of Research Analysts is not based
on any specific merchant banking, investment banking or brokerage service transactions.
Terms & Conditions:
This report has been prepared by MOSL and is meant for sole use by the recipient and not for circulation. The report and information contained herein is strictly confidential and may not be altered in any way, transmitted to,
copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of MOSL. The report is based on the facts, figures and information that are considered true,
correct, reliable and accurate. The intent of this report is not recommendatory in nature. The information is obtained from publicly available media or other sources believed to be reliable. Such information has not been
independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. The report
is prepared solely for informational purpose and does not constitute an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments for the clients. Though disseminated to all the
customers simultaneously, not all customers may receive this report at the same time. MOSL will not treat recipients as customers by virtue of their receiving this report.
Analyst Certification
The views expressed in this research report accurately reflect the personal views of the analyst(s) about the subject securities or issues, and no part of the compensation of the research analyst(s) was, is, or will be directly or indirectly
related to the specific recommendations and views expressed by research analyst(s) in this report.
Disclosure of Interest Statement
Analyst ownership of 1% or more securities
No
A graph of daily closing prices of securities is available at www.nseindia.com, www.bseindia.com. Research Analyst views on Subject Company may vary based on Fundamental research and Technical Research. Proprietary trading
desk of MOSL or its associates maintains arm's length distance with Research Team as all the activities are segregated from MOSL research activity and therefore it can have an independent view with regards to subject company
for which Research Team have expressed their views.
Regional Disclosures (outside India)
This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation
or which would subject MOSL & its group companies to registration or licensing requirements within such jurisdictions.
For Hong Kong:
This report is distributed in Hong Kong by Motilal Oswal capital Markets (Hong Kong) Private Limited, a licensed corporation (CE AYY-301) licensed and regulated by the Hong Kong Securities and Futures Commission (SFC) pursuant
to the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) "SFO". As per SEBI (Research Analyst Regulations) 2014 Motilal Oswal Securities (SEBI Reg No. INH000000412) has an agreement with Motilal Oswal
capital Markets (Hong Kong) Private Limited for distribution of research report in Hong Kong. This report is intended for distribution only to "Professional Investors" as defined in Part I of Schedule 1 to SFO. Any investment or investment
activity to which this document relates is only available to professional investor and will be engaged only with professional investors." Nothing here is an offer or solicitation of these securities, products and services in any jurisdiction
where their offer or sale is not qualified or exempt from registration. The Indian Analyst(s) who compile this report is/are not located in Hong Kong & are not conducting Research Analysis in Hong Kong.
For U.S.
Motilal Oswal Securities Limited (MOSL) is not a registered broker - dealer under the U.S. Securities Exchange Act of 1934, as amended (the"1934 act") and under applicable state laws in the United States. In addition MOSL is
not a registered investment adviser under the U.S. Investment Advisers Act of 1940, as amended (the "Advisers Act" and together with the 1934 Act, the "Acts), and under applicable state laws in the United States. Accordingly,
in the absence of specific exemption under the Acts, any brokerage and investment services provided by MOSL, including the products and services described herein are not available to or intended for U.S. persons. This report
is intended for distribution only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the Exchange Act and interpretations thereof by SEC (henceforth referred to as "major institutional investors"). This document must
not be acted on or relied on by persons who are not major institutional investors. Any investment or investment activity to which this document relates is only available to major institutional investors and will be engaged in only
with major institutional investors. In reliance on the exemption from registration provided by Rule 15a-6 of the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act") and interpretations thereof by the U.S. Securities
and Exchange Commission ("SEC") in order to conduct business with Institutional Investors based in the U.S., MOSL has entered into a chaperoning agreement with a U.S. registered broker-dealer, Motilal Oswal Securities International
Private Limited. ("MOSIPL"). Any business interaction pursuant to this report will have to be executed within the provisions of this chaperoning agreement.
The Research Analysts contributing to the report may not be registered /qualified as research analyst with FINRA. Such research analyst may not be associated persons of the U.S. registered broker-dealer, MOSIPL, and therefore,
may not be subject to NASD rule 2711 and NYSE Rule 472 restrictions on communication with a subject company, public appearances and trading securities held by a research analyst account.
For Singapore
Motilal Oswal Capital Markets Singapore Pte Limited is acting as an exempt financial advisor under section 23(1)(f) of the Financial Advisers Act(FAA) read with regulation 17(1)(d) of the Financial Advisors Regulations and is a subsidiary
of Motilal Oswal Securities Limited in India. This research is distributed in Singapore by Motilal Oswal Capital Markets Singapore Pte Limited and it is only directed in Singapore to accredited investors, as defined in the Financial
Advisers Regulations and the Securities and Futures Act (Chapter 289), as amended from time to time. In respect of any matter arising from or in connection with the research you could contact the following representatives of
Motilal Oswal Capital Markets Singapore Pte Limited:
Disclaimer:
The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person
or to the media or reproduced in any form, without prior written consent. This report and information herein is solely for informational purpose and may not be used or considered as an offer document or solicitation of offer
to buy or sell or subscribe for securities or other financial instruments. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate
to your specific circumstances. The securities discussed and opinions expressed in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial
positions and needs of specific recipient. This may not be taken in substitution for the exercise of independent judgment by any recipient. Each recipient of this document should make such investigations as it deems necessary
to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks
of such an investment. The investment discussed or views expressed may not be suitable for all investors. Certain transactions -including those involving futures, options, another derivative products as well as non-investment grade
securities - involve substantial risk and are not suitable for all investors. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information and opinions contained in this
document. The Disclosures of Interest Statement incorporated in this document is provided solely to enhance the transparency and should not be treated as endorsement of the views expressed in the report. This information
is subject to change without any prior notice. The Company reserves the right to make modifications and alternations to this statement as may be required from time to time without any prior approval. MOSL, its associates, their
directors and the employees may from time to time, effect or have effected an own account transaction in, or deal as principal or agent in or for the securities mentioned in this document. They may perform or seek to perform
investment banking or other services for, or solicit investment banking or other business from, any company referred to in this report. Each of these entities functions as a separate, distinct and independent of each other. The recipient
should take this into account before interpreting the document. This report has been prepared on the basis of information that is already available in publicly accessible media or developed through analysis of MOSL. The views
expressed are those of the analyst, and the Company may or may not subscribe to all the views expressed therein. This document is being supplied to you solely for your information and may not be reproduced, redistributed or
passed on, directly or indirectly, to any other person or published, copied, in whole or in part, for any purpose. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident
of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject MOSL to any registration or licensing requirement
within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves
of and to observe such restriction. Neither the Firm, not its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or
lost profits that may arise from or in connection with the use of the information. The person accessing this information specifically agrees to exempt MOSL or any of its affiliates or employees from, any and all responsibility/liability
arising from such misuse and agrees not to hold MOSL or any of its affiliates or employees responsible for any such misuse and further agrees to hold MOSL or any of its affiliates or employees free and harmless from all losses,
costs, damages, expenses that may be suffered by the person accessing this information due to any errors and delays.
Registered Office Address: Motilal Oswal Tower, Rahimtullah Sayani Road, Opposite Parel ST Depot, Prabhadevi, Mumbai-400025; Tel No.: 022-3980 4263; www.motilaloswal.com. Correspondence Address: Palm Spring Centre,
2nd Floor, Palm Court Complex, New Link Road, Malad (West), Mumbai- 400 064. Tel No: 022 3080 1000. Compliance Officer: Neeraj Agarwal, Email Id: na@motilaloswal.com, Contact No.:022-30801085.
Registration details of group entities.: MOSL: NSE (Cash): INB231041238; NSE (F&O): INF231041238; NSE (CD): INE231041238; BSE (Cash): INB011041257; BSE(F&O): INF011041257; BSE(CD); MSE(Cash): INB261041231; MSE(F&O):
INF261041231; MSE(CD): INE261041231; CDSL: IN-DP-16-2015; NSDL: IN-DP-NSDL-152-2000; Research Analyst: INH000000412. AMFI: ARN 17397. Investment Adviser: INA000007100. Motilal Oswal Asset Management Company Ltd.
(MOAMC): PMS (Registration No.: INP000000670) offers PMS and Mutual Funds products. Motilal Oswal Wealth Management Ltd. (MOWML): PMS (Registration No.: INP000004409) offers wealth management solutions. *Motilal
Oswal Securities Ltd. is a distributor of Mutual Funds, PMS, Fixed Deposit, Bond, NCDs, Insurance and IPO products. * Motilal Oswal Commodities Broker Pvt. Ltd. offers Commodities Products. * Motilal Oswal Real Estate Investment
Advisors II Pvt. Ltd. offers Real Estate products. * Motilal Oswal Private Equity Investment Advisors Pvt. Ltd. offers Private Equity products